Sunshine Act Payment Comparisons Likely Cloudy Due To Disclosure Judgment Calls
Executive Summary
Some answers to industry questions about ambiguity in sunshine regulations may come through enforcement actions, Sidley Austin’s James Stansel says.
You may also be interested in...
Sunshine In Your Pocket: Mobile Apps Help Docs Track Drug Firm Payments
CMS equips doctors to follow their payments from drug manufacturers so discrepancies can be found early and disagreements resolved prior to submission of the data, which companies began collecting Aug. 1.
Novartis Investigation Confirms Conflict Of Interest In Diovan Trial; Japan Health Ministry Looking For More
The third-party investigation into Japan trials of Diovan reveals no evidence of “willful manipulation” of data, but MHLW may look further into the trials.
Novartis Investigation Confirms Conflict Of Interest in Diovan Trial; Japan Health Ministry Looking For More
The third-party investigation into Japan trials of Diovan reveals no evidence of “willful manipulation” of data, but MHLW may look further into the trials.